111 (NASDAQ:YI - Get Free Report)'s stock had its "sell (e+)" rating reiterated by Weiss Ratings in a research note issued on Saturday,Weiss Ratings reports.
111 Stock Down 0.1%
Shares of NASDAQ:YI traded down $0.01 during trading on Friday, reaching $7.98. The stock had a trading volume of 5,535 shares, compared to its average volume of 23,614. The stock has a market cap of $68.24 million, a P/E ratio of -2.00 and a beta of 0.47. The business has a fifty day moving average price of $8.26 and a 200-day moving average price of $7.40. 111 has a fifty-two week low of $4.15 and a fifty-two week high of $14.10.
111 (NASDAQ:YI - Get Free Report) last issued its quarterly earnings results on Thursday, March 20th. The company reported ($0.04) earnings per share for the quarter. The business had revenue of $527.14 million during the quarter.
Institutional Investors Weigh In On 111
A number of institutional investors have recently added to or reduced their stakes in YI. JPMorgan Chase & Co. lifted its stake in shares of 111 by 43,619.9% in the 4th quarter. JPMorgan Chase & Co. now owns 306,039 shares of the company's stock valued at $191,000 after purchasing an additional 305,339 shares in the last quarter. FIL Ltd purchased a new stake in 111 during the fourth quarter worth approximately $450,000. Connor Clark & Lunn Investment Management Ltd. acquired a new stake in shares of 111 in the first quarter worth $92,000. Deuterium Capital Management LLC acquired a new position in shares of 111 during the 1st quarter valued at $81,000. Finally, Napean Trading & Investment Co Singapore PTE Ltd acquired a new position in shares of 111 during the 4th quarter valued at $245,000. Hedge funds and other institutional investors own 21.32% of the company's stock.
About 111
(
Get Free Report)
111, Inc engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies.
Featured Stories
Before you consider 111, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and 111 wasn't on the list.
While 111 currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
